http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017175808-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d71a3e23389a3bca747290fc6464cf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a49a0e5b69f8635b35b6b2f594687e61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb12b7f4deb107cd0bf7528e8b34ba30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15108dc37bbaa72b7cecfb407968668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b6353376d919d814172b9a6c4e9abe8
publicationDate 2017-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017175808-A1
titleOfInvention Therapeutic/prophylactic agent for graft-versus-host disease, fibrocyte invasion inhibitor, and inhibitor against tear reduction and reduction in goblet cells
abstract Provided are a new therapeutic/prophylactic agent for graft-versus-host disease, a fibrocyte invasion inhibitor, and an inhibitor against tear reduction and reduction in goblet cells. A therapeutic/prophylactic method for graft- versus-host disease comprises administering phenylbutyric acid or a pharmacologically acceptable salt thereof to a patient in need thereof. The graft-versus-host disease is preferably one acquired after a bone-marrow transplant. Also, the graft-versus-host disease is preferably one in the eyes.
priorityDate 2016-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009078977-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009051777-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226574573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001

Total number of triples: 28.